SCNX
Scienture Holdings, Inc.
Key Financials
Gross Profit
$331482
↑ 5420.1%
Net Income
$-41512264
↓ 557.9%
Revenue
$431609
↑ 215.9%
Operating Income
$-42590842
↓ 189.7%
EPS (Diluted)
$-2.70
↓ 208.9%
Total Liabilities
$14.1M
↓ 45.5%
Total Assets
$84.2M
↓ 19.7%
Cash & Equivalents
$6.7M
↑ 4285.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| 8-K | 5/1/2026 | View on SEC |
| 10-K/A | 4/30/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 4 | 3/12/2026 | View on SEC |
| 4 | 3/12/2026 | View on SEC |
| 8-K | 11/18/2025 | View on SEC |
| 8-K | 11/14/2025 | View on SEC |
| SCHEDULE 13G/A | 11/14/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SCNX |
| Company Name | Scienture Holdings, Inc. |
| CIK | 1382574 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (800) 261 0281 |